Fang Liu
About Fang Liu
Fang Liu is a DMPK Scientist at ORIC Pharmaceuticals Inc., where he has worked since 2021. He holds a PhD in Pharmaceutics and Drug Design from the University of the Pacific and has extensive experience in mass spectrometry and ADME-related experiments.
Current Role at ORIC Pharmaceuticals
Fang Liu currently serves as a DMPK Scientist at ORIC Pharmaceuticals Inc., a role he has held since 2021. In this position, he has developed LC-MS/MS methods for synthesized small molecules and peptides. His work focuses on drug metabolism and pharmacokinetics, contributing to the understanding of how drugs behave in biological systems.
Previous Experience at University of the Pacific
Fang Liu worked at the University of the Pacific in multiple capacities. He served as a Mass Spectrometer Curator from 2017 to 2018, where he managed and maintained mass spectrometry equipment. Additionally, he was a Graduate Teaching Assistant from 2015 to 2021, supporting the educational needs of students in the Stockton, California area.
Education and Expertise
Fang Liu holds a Doctor of Philosophy (PhD) in Pharmaceutics and Drug Design from the University of the Pacific, which he completed from 2015 to 2021. He also earned a Master's degree in Medicinal and Pharmaceutical Chemistry from China Pharmaceutical University, where he studied from 2012 to 2015. His academic background includes a Bachelor's degree in the same field from China Pharmaceutical University, completed from 2008 to 2012.
Technical Skills and Methodologies
Fang Liu possesses substantial experience in designing and executing both in vitro and in vivo ADME-related experiments. He utilizes a variety of mass spectrometer instruments, including triple quadrupole, MALDI-TOF, and orbitrap, for the characterization of small molecules, peptides, and proteins. His technical skills are integral to his role in drug development.